KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Liabilities and Shareholders Equity (2016 - 2025)

AbbVie (ABBV) has disclosed Liabilities and Shareholders Equity for 14 consecutive years, with $134.0 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 0.89% to $134.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $541.2 billion through Dec 2025, down 4.95% year-over-year, with the annual reading at $134.0 billion for FY2025, 0.89% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $134.0 billion at AbbVie, roughly flat from $133.9 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $150.5 billion in Q1 2021, with the low at $133.9 billion in Q3 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $140.6 billion, with a median of $140.1 billion recorded in 2022.
  • The sharpest move saw Liabilities and Shareholders Equity surged 65.02% in 2021, then decreased 8.54% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $146.5 billion in 2021, then decreased by 5.27% to $138.8 billion in 2022, then dropped by 2.95% to $134.7 billion in 2023, then increased by 0.33% to $135.2 billion in 2024, then fell by 0.89% to $134.0 billion in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $134.0 billion, $133.9 billion, and $137.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.